Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioCryst Pharmaceuticals, Inc. - Common Stock (NQ:BCRX)

10.37 -0.35 (-3.26%)
Streaming Delayed Price Updated: 12:14 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioCryst Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
What's Going On With BioCryst Stock After Earnings? ↗
BioCryst reported quarterly losses of 28 cents per share, missing the analyst consensus estimate of losses of 24 cents by 16.67% and representing a 26.32% increase over losses of 38 cents per share... 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗
U.S. stock futures were lower this morning, with the Dow futures trading lower by over 50 points on Monday. 
Via Benzinga
Topics Stocks
News headline image
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results. 
Via Benzinga
News headline image
Where BioCryst Pharma Stands With Analysts ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 26, 2024 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million. 
Via Benzinga
News headline image
A Preview Of BioCryst Pharma's Earnings ↗
 
Via Benzinga
News headline image
What's Going On With BioCryst Pharmaceuticals Stock? ↗
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) shares are trading higher Monday. 
Via Benzinga
News headline image
What 7 Analyst Ratings Have To Say About BioCryst Pharma ↗
 
Via Benzinga
News headline image
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... 
Via Benzinga
News headline image
BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript ↗
BCRX earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
3 Magnificent Growth Stocks to Buy on the Dip ↗
These three biotech stocks are attractive buys right now. 
Via The Motley Fool
News headline image
Analyst Expectations for BioCryst Pharma's Future ↗
 
Via Benzinga
News headline image
Why BioCryst Pharmaceuticals Stock Is Soaring Today ↗
The biotech's Q1 earnings report contained a number of positives. 
Via The Motley Fool
News headline image
BioCryst Clocks 37.8% Revenue Growth In Q1 On Solid New Patient Growth ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023 ↗
 
Via Benzinga
News headline image
Recap: BioCryst Pharma Q1 Earnings ↗
 
Via Benzinga
News headline image
Why Shares of BioCryst Pharmaceuticals Jumped Today ↗
A day after the stock plummeted, it bounced back. 
Via The Motley Fool
News headline image
BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript ↗
BCRX earnings call for the period ending June 30, 2023. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023 ↗
 
Via Benzinga
News headline image
BioCryst Pharmaceuticals (BCRX) Q1 2023 Earnings Call Transcript ↗
BCRX earnings call for the period ending March 31, 2023. 
Via The Motley Fool
News headline image
Why Is BioCryst Pharmaceuticals (BCRX) Stock Down 8% Today? ↗
BioCryst Pharmaceuticals (BCRX) stock is slipping on Tuesday after the biotech company announced new funding to pay down debts. 
Via InvestorPlace
News headline image
Why BioCryst Pharmaceuticals Stock Is Sinking Today ↗
Investors didn't like the drugmaker's Q4 update. 
Via The Motley Fool
News headline image
Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Analyst Sees Attractive Entry Opportunity After BioCryst's Pipeline Setback ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023 ↗
 
Via Benzinga
News headline image
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023. 
Via Benzinga
News headline image
BioCryst Pharmaceuticals (BCRX) Q4 2022 Earnings Call Transcript ↗
BCRX earnings call for the period ending December 31, 2022. 
Via The Motley Fool
News headline image
Why BioCryst Pharmaceuticals Stock Is Sliding Today ↗
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Tuesday after the company reported worse-than-expected earnings results< 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.